Search results
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 12 hours agoWe recently received the first U.S. FDA gene therapy approval for Pfizer with FDA approval for Beqvez, a one-time gene therapy for adults with hemophilia...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 24 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 17 hours agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 4 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 21 hours agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 6 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 14 hours agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
US opens COVID vaccine to little kids, shots begin next week
AOL· 2 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 7 days agoThe study confirmed the vaccine's effectiveness and its importance to control of the disease, while...
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for...
Morningstar· 6 days agoPfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with ...